baber/WOPTO huggingface dataset:
Patent CA-2338509-A1 (CA)
Title: Gelling cold pack
Inventor: SABIN MARTIN W
IPC: A61F7/02
Filed: 1999-07-30
Abstract: The present invention provides a cold pack which utilizes the negative heat of solution of a material dissolving in a liquid. The cold pack further include s a gelling agent, which is activatable to form a gel. The gel provides a numb er of benefits, including better distribution of cold, increased cold persisten ce in the cold pack, and a more complete utilization of the ingredients of the cold pack than possible with prior art devices.
Patent CA-2338540-A1 (CA)
Title: A rapid method to detect duplex formation in sequencing by hybridization methods, a method for constructing containment structures for reagent interaction
Inventor: PROUDNIKOV DMITRI Y
IPC: C12Q1/6874
Filed: 1999-08-02
Abstract: A method for determining the existence of duplexes of oligonucleotide complementary molecules is provided whereby a plurality of immobilized oligonucleotide molecules, each of a specific length and each having a specific base sequence, is contacted with complementary, single stranded oligonucleotide molecules to form a duplex so as to facilitate intercalation  of a fluorescent dye between the base planes of the duplex. The invention al so provides for a method for constructing oligonucleotide matrices comprising confining light sensitive fluid to a surface, exposing said light-sensitive fluid to a light pattern so as to cause the fluid exposed to the light to polymerize into discrete units and adhere to the surface; and contacting eac h of the units with a set of different oligonucleotide molecules so as to allo w the molecules to disperse into the units.
Patent CA-2338543-A1 (CA)
Title: Method of direct identification of compound efficacy at a g protein-coupled orphan receptor
Inventor: BEHAN DOMINIC P
IPC: C07D233/42
Filed: 1999-07-30
Abstract: Disclosed herein are techniques for directly identifying candidate compounds  as agonists, partial agonists and/or, most preferably, inverse agonists, to endogenous, constitutively activated orphan G protein-coupled receptors. Suc h directly identified compounds can be utilized, most preferably, in pharmaceutical compositions.
Patent CA-2340481-A1 (CA)
Inventor: CHEN CHIN-CHEN
IPC: H04M11/04
Filed: 2001-03-12
Abstract: A mobile security system, which includes a warning signal transmitter unit installed in the place or equipment to be protected, an auto dialing unit having a signal receiver, and a cellular phone coupled to the auto dialing unit, wherein when the warning signal transmitter unit detects an abnormal condition, it immediately sends a warning signal to the signal receiver by radio, and the signal receiver immediately drives the auto dialing unit to dial a particular telephone number upon receipt of the warning signal; so as to inform a particular person or security center to take the necessary step.  The auto dialing unit can be a mechanical design, or an electronic design as desired.
Patent CA-2341750-A1 (CA)
Inventor: VENTURA SUSANNA
IPC: H01M6/16
Filed: 1999-08-20
Abstract: Secondary metal ion batteries are fabricated using a working electrolyte that is substantially incompatible with the anode material. This is accomplished by forming an SEI on the anode material at least in part using a compatible (i.e., SEI developing) electrolyte, and including a substantially incompatible (non-SEI forming) composition as the working electrolyte.
Patent CA-2342026-A1 (CA)
Title: Liquid-filled vibration isolator
Inventor: MURAI HIROTAKA
IPC: F16F13/14
Filed: 2001-03-26
Abstract: A liquid-filled vibration isolator includes an inner cylindrical metal member; a cylindrical intermediate metal member disposed outside the inner cylindrical metal member in a substantially coaxial manner and including a pair of ring portions disposed at corresponding axial ends thereof, a pair of connection portions integrally connecting the ring portions, and a pair of window portions defined by the ring portions and the connection portions; a rubber elastic-body connecting the intermediate metal member and the inner cylindrical metal member and having cavity portions corresponding to the window portions; and an outer cylindrical metal member fixedly disposed outside the intermediate metal member and sealed in a liquid-tight manner against the intermediate metal member by means of a rubber seal portion. The rubber elastic-body includes first and second diaphragm portions formed on the front side of the inner cylindrical metal member with respect to the front-rear direction of the vehicle, and third and fourth diaphragm portions formed on the rear side of the inner cylindrical metal member with respect to the front-rear direction of the vehicle. Among the first through fourth diaphragm portions, the first and forth diaphragm portions located diagonally opposite each other with respect to said inner cylindrical metal member are longer than the second and third diaphragm portions.
Patent CA-2342042-A1 (CA)
Title: Biosensor electromagnetic noise cancellation
Inventor: ZIVITZ MAURY
IPC: G01N33/487
Filed: 2001-03-27
Abstract: A biosensing cell assembly having a measurement loop with a test cell having an analyte reaction zone for amperometric measurement of a response current to determine analyte concentration and a noise cancellation loop arranged to be physically exposed to the same electromagnetic environment as the measurement loop. The noise cancellation loop has a predetermined impedance within a range of the impedance of the test cell analyte reaction zone and provides a current to cancel or reduce the effects of the electromagnetic environment on the measurement loop.
Patent CA-2344233-A1 (CA)
Inventor: VAN GESTEL WILHELMUS J
IPC: G11B20/12
Filed: 2000-07-12
Abstract: L'invention traite de l'enregistrement d'informations, en particulier d'un signal audio et/ou vidéo en temps réel, sur une piste (3) d'enregistrement d'un support d'enregistrement (2) divisé en blocs (45). Ledit support contient une liste de défectueux (BS) d'adresses de blocs (45*) connus. Cette liste est lu et, pendant le processus d'enregistrement, les blocs défectueux sont omis. Le processus d'enregistrement est exécuté sans procéder à une vérification par lecture avant écriture de façon à accélérer ledit processus. On actualise la liste de défectueux en notant, pendant la lecture, les blocs de lecture problématiques et en incluant les adresses desdits blocs dans la liste de défectueux sur le support d'enregistrement.
Patent CA-2351920-A1 (CA)
Title: Rotational control apparatus
Inventor: VATSAAS RICK
IPC: F16D25/062
Filed: 1996-07-16
Abstract: Rotational control apparatus (A) in the preferred forms of fan clutches is disclosed including shoulder bolts (78) extending through axially extending voids (146) formed in axially extending portion (66) and flange (76) of first and second shell housings (62, 68). The shoulder bolts (78) secure the shell housings (62, 68) together to prevent relative movement therebetween. The apparatus (A) further includes a piston (80) having tabs (144) extending from the outer periphery thereof into the voids (146) and including openings having bushings (134) therein for slideable receipt on the shoulder bolts (78). Springs (138) are mounted on standoffs (210) extending in the voids (146) and abutting with the shoulder of the shoulder bolts (78). A first O-ring (94, 234) is received on an axially extending, outer cylindrical surface of a first shoulder (92, 232) such that fluid pressure received in a cylinder (C) pushes the first O-ring (94, 234) against the annular, radially extending surface of the first shoulder (92, 232). In a preferred form, a second O-ring (238) is received on an axially extending outer cylindrical surface of a second shoulder (236). A step (240) includes an annular, radially extending surface for pushing the second O-ring (238) towards the annular, radially extending surface of the second shoulder (236) in the absence of fluid pressure in the cylinder (C).
Patent CA-2354024-A1 (CA)
Title: A recombinant vector expressing multiple costimulatory molecules and uses thereof
Inventor: PANICALI DENNIS
IPC: A61K35/12
Filed: 1999-11-12
Abstract: The present invention is a recombinant vector encoding and expressing at lea st three or more costimulatory molecules. The recombinant vector may additional ly contain a gene encoding one or more target antigens or immunological epitope  thereof. The synergistic effect of these costimulatory molecules on the enhanced activation of T cells is demonstrated. The degree of T-cell activation using recombinant vectors containing genes encoding three costimulatory molecules was far greater than the sum of recombinant vector constructs containing one costimulatory molecule and greater than the use of  two costimulatory molecules. Results employing the triple costimulatory vectors were most dramatic under conditions of either low levels of first signal or low stimulator to T-cell ratios. This phenomenon was observed with  both isolated CD4+ and CD8+ T cells. The recombinant vectors of the present invention are useful as immunogenes and vaccines against cancer and pathogen ic micro-organisms, and in providing host cells, including dendritic cells and splenocytes with enhanced antigen-presenting functions.
Patent CA-2355302-A1 (CA)
Inventor: ARNOULD JEAN-CLAUDE
IPC: A61K31/661
Filed: 1999-12-24
Abstract: The invention relates to the use of compounds of formula (I): wherein X is - C(O)-, -C(S)-, -C=NOH, or -CH(R7)- wherein R7 is hydrogen, hydroxy, C1- 7alkoxy, -OR8 or -NR8R9 (wherein R8 is a group -Y1R10 (wherein Y1 is a direc t bond, -C(O)-, -C(S)-, -S-, -C(O)O, -C(O)NR11-, -SO2- or -SO2NR12- (wherein R 11 and R12, which may be the same or different, each independently represents hydrogen, C1-3alkyl or C1-3alkoxyC2-3alkyl) and R10 is as defined herein, an d R9 includes hydrogen; R1, R2 and R3 are as defined herein and are preferably  methyl; R4, R5 and R6 are as defined herein with the proviso that R5 is not hydroxy, alkoxy, substituted alkoxy, -OPO3H2, -O-C1-7alkanoyl or benzyloxy; and salts thereof in the manufacture of a medicament for use in the producti on of a vascular damaging effect in warm-blooded animals such as humans. The present invention further relates to compounds of the formula (I), pharmaceutical compositions containing them, processes for their preparation  and to a method of treatment using the compounds to produce a vascular damaging effect in a warm-blooded animal such as a human. The compounds of formula (I) and the pharmaceutically acceptable salts thereof may be useful in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent CA-2360202-A1 (CA)
Title: Energy activatable material for the treatment of sebaceous gland disorders
Inventor: ANDERSON RICHARD ROX
IPC: A61K41/00
Filed: 1999-12-16
Abstract: Laser treatments of sebaceous gland disorders with laser sensitive dyes are disclosed. A preferred laser treatment includes topical application of an energy activatable material to the skin followed by laser irradiation.
Patent CA-2360648-A1 (CA)
Title: Ameliorations apportees a ou se rapportant aux sphygmomanometres et autres dispositifs
Inventor: WOOLLEY JACK
IPC: F16H31/00
Filed: 2000-01-28
Abstract: L'invention concerne un sphygmomanomètre (10; 110) comprenant des moyens de manchette (11) pourvus d'une manchette gonflable (12) d'une longueur susceptible d'être gonflée, et des moyens de constriction (30; 130) destinés à resserrer ladite manchette (12) au niveau de différentes positions le long de celle-ci, ce qui fait varier sa longueur de manière continue, d'une longueur maximum à une longueur efficace inférieure à ladite longueur maximum, et à sélectionner ou à déterminer une longueur efficace désirée quelconque de ladite manchette dans une plage d'environ 20 % à 100 % de la longueur maximum. Les moyens de manchette comprennent des moyens de fixation (13, 15; 115, 150) dotés d'une première et d'une seconde parties (13, 15; 115, 150) à engagement réciproque, espacées longitudinalement sur la manchette (12) lorsque cette dernière se gonfle, l'une desdites parties (13, 15; 115, 150) étant fixée à ladite manchette par des moyens permettant à la manchette fixée, lorsqu'on l'utilise, d'adopter une forme tronconique de sorte qu'elle peut loger un membre progressivement réduit d'un sujet, par exemple la partie supérieure du bras d'un patient dont on prend la pression sanguine. Lesdits moyens de fixation (13, 15; 115, 150) et la manchette (12) peuvent être reliés pivotants afin que ladite manchette puisse prendre une forme tronconique à angle conique variable, et donc loger automatiquement les degrés de variation de la réduction progressive. Un mécanisme à cliquet (140, 133) libérable à une main est destiné à éviter que la manchette se retire d'un logement dudit mécanisme, ce mécanisme comprenant des moyens de libération (144, 145t) fonctionnant de façon à autoriser ce retrait. Ledit mécanisme à cliquet (140, 133) libérable comprend un élément d'entrée rotatif sous forme d'une unité de bouton (140) coaxial audit élément, et un élément de sortie rotatif sous forme de tige (133), la rotation de l'élément d'entrée (140) dans un premier sens entraînant la rotation de l'élément de sortie (133) dans le même sens, mais empêchant la rotation dudit de l'élément de sortie (133) dans un second sens opposé, et la rotation de l'élément d'entrée (140) dans ce second sens opposé permettant la rotation de l'élément de sortie (133) dans ce même second sens.
Patent CA-2361424-A1 (CA)
Title: Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
Inventor: MUCHNIK ANNA
IPC: A61K47/44
Filed: 2000-02-02
Abstract: This invention relates to stable non-aqueous single phase viscous vehicles and to formulations utilizing such vehicles.  The formulations comprise at least one beneficial agent uniformly suspended in the vehicle. The formulation is capable of being stored at temperatures ranging from cold to body temperature for long periods of time. The formulations are capable of being uniformly delivered from drug delivery systems at an exit shear rate of between about 1 to 1 x 101 reciprocal second.
Patent CA-2362026-A1 (CA)
Inventor: MAGNUS LESLIE
IPC: A61P13/10
Filed: 2000-01-27
Abstract: The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid to treat incontinence.
Patent CA-2364340-A1 (CA)
Inventor: ERIKSSON JAN A
IPC: B62D13/04
Filed: 2001-12-05
Abstract: A log hauler having a wheeled tractor and one or more wheeled log trailers with support wheels which are individually steerable to permit the log hauler to travel in a serpentine manner through a tree harvesting area. The support wheels are vertically adjustable to provide stability as the log hauler traverses uneven ground.
Patent CA-2365810-A1 (CA)
Inventor: CLARKE TIMOTHY JOHN
IPC: A01G31/02
Filed: 2001-12-21
Abstract: The first extrusional, inert grow medium system. A re-useable, self-cleaning, inert grow medium can be integrated. into a closed hydroponics system designed to withstand decades (centuries) of repeated use in the roughest and dirtiest of third (or first) world conditions and requiring no skills other than basic dexterity to operate and maintain.
Patent CA-2365816-A1 (CA)
Inventor: OENBRINK GEORG
IPC: C08L33/06
Filed: 2001-12-19
Abstract: A molding composition which comprises the following components:    I. from 60 to 96.6 parts by weight of thermoplastic polyesters, II. from 3 to 39.5 parts by weight of an impact-modifying component which contains anhydride groups, III. from 0.4 to 20 parts by weight of a copolymer which contains units of the monomers a) .alpha.-olefin, b) acrylic compound, and also c) olefinically unsaturated epoxide, carboxylic anhydride, carboximide, oxazoline or oxazinone, where the total of the parts by weight of components I, II and III is 100, has improved low-temperature impact strength.
Patent CA-2366181-A1 (CA)
Title: Toaster pastry
Inventor: PEROG DERRY-ANNE
IPC: A23L19/00
Filed: 2001-12-27
Abstract: A dough and a filling for making a toaster pastry and a method for making same. A method of forming the dough for the toaster pastry, comprises forming a blend of ingredients comprising wheat flour of from about 25 to about 44% by weight of ingredients for the dough, wheat farina of from about 13 to about 35% by weight of ingredients for the dough, shortening of from about 1.5 to about 2.5% by weight of ingredients for the dough, and water of from about 25 to about 35% by weight of ingredients for the dough; adding puff pastry shortening in the form of cubes such that the amount of puff pastry shortening is in the range of from about 5 to about 15% by weight of the ingredients for the pastry; and blending the ingredients such that a heterogeneous mixture of the cubes of shortening in the remainder of the ingredients is obtained. In a preferred aspect, the method further comprises forming the dough into a layered structure, the layered structure comprising a single base sheet of the dough covered with a pastry filling, with a single top sheet of the pastry blend of the dough applied thereover.
Patent CA-2367695-A1 (CA)
Title: Heteroaryl diazacycloalkanes, their preparation and use
Inventor: PETERS DAN
IPC: A61P25/34
Filed: 2000-04-19
Abstract: The present invention relates to novel heteroaryl diazacycloalkane derivatives which are found to be cholinergic ligands at the nicotinic Acetyl Choline Receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neurodegeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
Patent CA-2371787-A1 (CA)
Inventor: MORIN DENIS
IPC: B62D55/24
Filed: 2000-02-11
Abstract: A novel mountain snowmobile comprises a frame, an engine disposed on the frame, at least one ski disposed on the frame, a seat disposed on the frame, a steering device disposed on the frame forward of the seat that is operatively connected to the at least one ski for steering the snowmobile. and a novel long length drive track disposed below the frame and connected operatively to the engine for propulsion of the snowmobile. The novel drive track comprises an endless body having a ground-engaging outer surface with a central portion flanked by first and second lateral portions, a plurality of longitudinally spaced reinforcing rods disposed in the body along a transverse direction of the body. The rods define a plurality of pitches, and a plurality of profiles project from the outer surface of the body along the plurality of pitches. A plurality of non-profile regions is defined along the plurality of pitches, and the profiles and profile-free regions define a pattern for each pitch. The pitch pattern for the novel track has a six pitch tread pattern which repeats every successive sixsomes of pitches. A height profile that varies between the first and second lateral portions is defined by the profiles. Such height profile has each profile with a height of not less than about 1 1/4 inches. The long length track has a length greater than about 141 inches.
Patent CA-2371966-A1 (CA)
Title: Systeme de stockage double voie inverse
Inventor: REES PHIL
IPC: B65G1/04
Filed: 2000-04-11
Abstract: L'invention concerne un convoyeur comportant une série d'allées de stockage destinées à recevoir des articles dans une pluralité de couloirs de stockage. Un article sélectionné se déplaçant sur la ligne du convoyeur peut être dirigé vers un poste navette au niveau duquel ledit article est chargé sur une navette en vue de son déplacement dans une allée de stockage. L'article est ensuite déplacé le long de l'allée de stockage afin d'être placé dans l'un des nombreux couloirs de stockage. L'article peut être retiré du couloir de stockage et replacé sur le système transporteur en vue de sa sortie.
Patent CA-2373049-A1 (CA)
Title: Method and apparatus for compensating for dot gain in stochastic printing
Inventor: HILL DE LA TORRE JESUS
IPC: B41C1/00
Filed: 2000-05-17
Abstract: A method of compensating for dot gain in printing with stochastic screens comprises obtaining continuous tone CMYK files and screening the files at a resolution that is lower than the resolution of an output device that will b e used to print the files. The lower resolution stochastically screened files are then expanded to the resolution of the output device, thereby effectivel y increasing the size of the dots by creating a number of subdots for each dot  in the lower resolution stochastically screened files. Subdots within the expanded stochastically screened files can then be selectively removed to compensate for dot gain. In addition, overlapping dots in the screened CMYK files are removed and additional stochastically screened files are created that print a dot of a color of the previously overlapping dots and at the location of the previously overlapping dots to prevent colors from running together when printing on certain media. Finally, the removal of subdots in the expanded CMYK files can be performed to correct the color of the images when the expanded stochastically screened file is printed.
Patent CA-2373177-A1 (CA)
Title: Object modeling for computer simulation and animation
Inventor: LI XIN
IPC: G06T13/20
Filed: 2000-05-05
Abstract: An abstract simulation entity definition for use in real time computer simulation and animation (100) encapsulates both the physical and behavioral characteristics of a display object. The simulation entity provides a unique "genetic plan" (106) containing abstract attributes that may be shared among objects. Each simulation entity has the knowledge of common operations, and the ability to communicate with other simulation entities via communication pathway (102).
Patent CA-2374252-A1 (CA)
Inventor: WELLER KEITH J
IPC: C07F7/18
Filed: 2000-06-07
Abstract: A method for preparing acrylamidoalkylalkoxysilanes from aminoalkylalkoxysilanes and acrylate esters is described wherein at least two inhibitors and an amidation catalyst are used in an elevated temperature reaction.
Patent CA-2380852-A1 (CA)
Title: Tricyclic compounds having spiro union
Inventor: NISHIDA HIDEMITSU
IPC: A61P7/02
Filed: 2000-06-30
Abstract: This invention relates to tricyclic compounds having spiro union represented by the following formula (I) or its salt which is useful as a drug, and in particular, as an inhibitor for activated blood coagulation factor X, which can be administered orally and which exhibits strong anticoagulation action.   (see formula I) The invention also relates to a pharmacophore which was derived from the compound and is useful in molecular designing of the FXa inhibitor.